Search company, investor...

ViaCell

viacellinc.com

Total Raised

$104.79M

Investors Count

17

Deal Terms

1

Funding, Valuation & Revenue

10 Fundings

ViaCell's latest funding round was a Acquired for on November 7, 2007.

ViaCell's latest post-money valuation is from November 2007.

Sign up for a free trial to see ViaCell's valuations in November 2007 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/7/2007

Acquired

$99M

0

FY undefined

10/11/2003

Unattributed VC - VIII

$17.52M

0

FY undefined

10/18/2001

Unattributed VC - VII

$18.51M

0

FY undefined

11/7/2000

Unattributed VC - VI

$99M

0

FY undefined

0

4/13/2000

Unattributed VC - V

$99M

0

FY undefined

0

Date

11/7/2007

10/11/2003

10/18/2001

11/7/2000

4/13/2000

Round

Acquired

Unattributed VC - VIII

Unattributed VC - VII

Unattributed VC - VI

Unattributed VC - V

Amount

$17.52M

$18.51M

$99M

$99M

Investors

Valuation

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

0

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

ViaCell Deal Terms

1 Deal Term

ViaCell's deal structure is available for 1 funding round, including their Acquired from November 07, 2007.

Round

Acquired

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

ViaCell Investors

17 Investors

ViaCell has 17 investors. PerkinElmer invested in ViaCell's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/7/2007

11/7/2007

1
Acquired

Corporation

Massachusetts

11/7/2000

10/11/2003

3
Unattributed VC - VI, Unattributed VC - VII (2001), Unattributed VC - VIII (2003)

Venture Capital

Arkansas

11/7/2000

10/11/2003

3
Unattributed VC - VI, Unattributed VC - VII (2001), Unattributed VC - VIII (2003)

Corporate Venture

Singapore

00/00/0000

00/00/0000

MPM Capital

Subscribe to see more

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Isabella Capital

Subscribe to see more

Venture Capital

Ohio

First funding

11/7/2007

11/7/2000

11/7/2000

00/00/0000

00/00/0000

Last Funding

11/7/2007

10/11/2003

10/11/2003

00/00/0000

00/00/0000

Investor

MPM Capital

Isabella Capital

Rounds

1
Acquired
3
Unattributed VC - VI, Unattributed VC - VII (2001), Unattributed VC - VIII (2003)
3
Unattributed VC - VI, Unattributed VC - VII (2001), Unattributed VC - VIII (2003)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Venture Capital

Corporate Venture

Venture Capital

Venture Capital

Location

Massachusetts

Arkansas

Singapore

Massachusetts

Ohio

ViaCell Acquisitions

1 Acquisition

ViaCell acquired 1 company. Their latest acquisition was Kourion Therapeutics on September 30, 2003.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/30/2003

Series A

$99M

$10.24M

Acquired

1

Date

9/30/2003

Investment Stage

Series A

Companies

Valuation

$99M

Total Funding

$10.24M

Note

Acquired

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.